In order to further explore how we can create a Virtuous Cycle to better integrate data teams into a biotech organization, I want to go through another case study, this time looking at how we can get analysis from your data team back to the bench scientists. Again, I’m going to split things up into multiple emails, to keep them a readable length (and maybe build a sense of anticipation).
Considering the frequency of cell line contamination, your example hardly seems farfetched.
e.g. https://www.nature.com/articles/2402610
https://en.wikipedia.org/wiki/List_of_contaminated_cell_lines